In the interest of a happy ending… “One iss

In the interest of a happy ending…

“One issue, if we're talking about this seriously, is the story's optics or lack thereof. Like some other pharma stories, it's not super exciting to look at FDA meetings, drug trials, data, so there's likely a ceiling as a miniseries or MOW.”

I agree a happy ending would be necessary for anybody to be interested.

I can only offer foreplay.

A wrap-around Dr J lay-up

FDA holds lifted

1 long COVID paper published
5 papers in peer review
1 paper in internal prep for peer review

Drug only Glioblastoma murine study at Einstein

Samsung amicable deferral

Phase II MSS CRC self-funded trial
Potential $31M warrant raise
Great buying opportunity

Unassailable data from Inflammatory Biomarker study
Interestingly absent of elevated transsexuals in the new protocol.

Multiple partnership interests finalizing in the near future

Including an Investigator initiated study in Alzheimer’s

GvHD updates at trial site

Trademarks revitalized

HIV cure

Stem cell transplants

ABSCI or other .ai partners

Long acting

Forever acting Intramuscular AAV

17 new strains

90+ Ohm’s list

Within 5 months, a settlement worth in the ballpark of $100M

Oh, and anything Maravoric can do, we can do better.

Am i forgetting anything??